πŸ‡ΊπŸ‡Έ FDA
Patent

US 11639364

Potent sialyltransferase inhibitors

granted A61PA61P31/04A61P31/12

Quick answer

US patent 11639364 (Potent sialyltransferase inhibitors) held by Stichting Radboud universitair medisch centrum expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Stichting Radboud universitair medisch centrum
Grant date
Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P31/04, A61P31/12, A61P35/00